VAERS 2051143
MERCK & CO. INC. · HPV (GARDASIL 9) · Charge UOO7652
- Staat
- WA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 20.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Symptomtext
MMR II Lot T001213 Expiration date 1/12/2022 was administered on 1/18/2022. There were no adverse effects to patient. I contacted Merck & Company to discuss with representative if a re-vaccination was necessary. Merck stated that as long as there were no temperature excursions and with the vaccine storage, they stand behind their product with in-house data to still be potent beyond the 6 days usage (after expiration date).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -